Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome

Zurina Romay-Penabad, Renan Aguilar-Valenzuela, Rolf T. Urbanus, Ronald H W M Derksen, Maarten T T Pennings, Elizabeth Papalardo, Tuya Shilagard, Gracie Vargas, Yong Hwang, Philip G. De Groot, Silvia S. Pierangeli

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Antiphospholipid (aPL)/anti-β2 glycoprotein I (anti-β2GPI) antibodies stimulates tissue factor (TF) expression within vasculature and in blood cells, thereby leading to increased thrombosis. Several cellular receptors have been proposed to mediate these effects, but no convincing evidence for the involvement of a specific one has been provided. We investigated the role of Apolipoprotein E receptor 2 (ApoER2′) on the pathogenic effects of a patient-derived polyclonal aPL IgG preparation (IgG-APS), a murine anti-β2GPI monoclonal antibody (E7) and of a constructed dimeric β2GPI I (dimer), which in vitro mimics β2GPI-antibody immune complexes, using an animal model of thrombosis, and ApoER2-deficient (-/-) mice. In wild type mice, IgG-APS, E7 and the dimer increased thrombus formation, carotid artery TF activity as well as peritoneal macrophage TF activity/expression. Those pathogenic effects were significantly reduced in ApoER2 (-/-) mice. In addition, those effects induced by the IgG-APS, by E7 and by the dimer were inhibited by treatment of wild-type mice with soluble binding domain 1 of ApoER2 (sBD1). Altogether these data show that ApoER2 is involved in pathogenesis of antiphospholipids antibodies.

Original languageEnglish (US)
Pages (from-to)1408-1414
Number of pages7
JournalBlood
Volume117
Issue number4
DOIs
StatePublished - Jan 27 2011

Fingerprint

Antiphospholipid Syndrome
Thromboplastin
Immunoglobulin G
Dimers
Thrombosis
Glycoproteins
Antiphospholipid Antibodies
Antibodies
Macrophages
Peritoneal Macrophages
Antigen-Antibody Complex
Carotid Arteries
Blood Cells
Animals
Blood
Animal Models
Monoclonal Antibodies
Cells
low density lipoprotein receptor-related protein 8

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Romay-Penabad, Z., Aguilar-Valenzuela, R., Urbanus, R. T., Derksen, R. H. W. M., Pennings, M. T. T., Papalardo, E., ... Pierangeli, S. S. (2011). Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. Blood, 117(4), 1408-1414. https://doi.org/10.1182/blood-2010-07-299099

Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. / Romay-Penabad, Zurina; Aguilar-Valenzuela, Renan; Urbanus, Rolf T.; Derksen, Ronald H W M; Pennings, Maarten T T; Papalardo, Elizabeth; Shilagard, Tuya; Vargas, Gracie; Hwang, Yong; De Groot, Philip G.; Pierangeli, Silvia S.

In: Blood, Vol. 117, No. 4, 27.01.2011, p. 1408-1414.

Research output: Contribution to journalArticle

Romay-Penabad, Z, Aguilar-Valenzuela, R, Urbanus, RT, Derksen, RHWM, Pennings, MTT, Papalardo, E, Shilagard, T, Vargas, G, Hwang, Y, De Groot, PG & Pierangeli, SS 2011, 'Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome', Blood, vol. 117, no. 4, pp. 1408-1414. https://doi.org/10.1182/blood-2010-07-299099
Romay-Penabad Z, Aguilar-Valenzuela R, Urbanus RT, Derksen RHWM, Pennings MTT, Papalardo E et al. Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. Blood. 2011 Jan 27;117(4):1408-1414. https://doi.org/10.1182/blood-2010-07-299099
Romay-Penabad, Zurina ; Aguilar-Valenzuela, Renan ; Urbanus, Rolf T. ; Derksen, Ronald H W M ; Pennings, Maarten T T ; Papalardo, Elizabeth ; Shilagard, Tuya ; Vargas, Gracie ; Hwang, Yong ; De Groot, Philip G. ; Pierangeli, Silvia S. / Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. In: Blood. 2011 ; Vol. 117, No. 4. pp. 1408-1414.
@article{67d81f59c5f442938760debbe2c17d76,
title = "Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome",
abstract = "Antiphospholipid (aPL)/anti-β2 glycoprotein I (anti-β2GPI) antibodies stimulates tissue factor (TF) expression within vasculature and in blood cells, thereby leading to increased thrombosis. Several cellular receptors have been proposed to mediate these effects, but no convincing evidence for the involvement of a specific one has been provided. We investigated the role of Apolipoprotein E receptor 2 (ApoER2′) on the pathogenic effects of a patient-derived polyclonal aPL IgG preparation (IgG-APS), a murine anti-β2GPI monoclonal antibody (E7) and of a constructed dimeric β2GPI I (dimer), which in vitro mimics β2GPI-antibody immune complexes, using an animal model of thrombosis, and ApoER2-deficient (-/-) mice. In wild type mice, IgG-APS, E7 and the dimer increased thrombus formation, carotid artery TF activity as well as peritoneal macrophage TF activity/expression. Those pathogenic effects were significantly reduced in ApoER2 (-/-) mice. In addition, those effects induced by the IgG-APS, by E7 and by the dimer were inhibited by treatment of wild-type mice with soluble binding domain 1 of ApoER2 (sBD1). Altogether these data show that ApoER2 is involved in pathogenesis of antiphospholipids antibodies.",
author = "Zurina Romay-Penabad and Renan Aguilar-Valenzuela and Urbanus, {Rolf T.} and Derksen, {Ronald H W M} and Pennings, {Maarten T T} and Elizabeth Papalardo and Tuya Shilagard and Gracie Vargas and Yong Hwang and {De Groot}, {Philip G.} and Pierangeli, {Silvia S.}",
year = "2011",
month = "1",
day = "27",
doi = "10.1182/blood-2010-07-299099",
language = "English (US)",
volume = "117",
pages = "1408--1414",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome

AU - Romay-Penabad, Zurina

AU - Aguilar-Valenzuela, Renan

AU - Urbanus, Rolf T.

AU - Derksen, Ronald H W M

AU - Pennings, Maarten T T

AU - Papalardo, Elizabeth

AU - Shilagard, Tuya

AU - Vargas, Gracie

AU - Hwang, Yong

AU - De Groot, Philip G.

AU - Pierangeli, Silvia S.

PY - 2011/1/27

Y1 - 2011/1/27

N2 - Antiphospholipid (aPL)/anti-β2 glycoprotein I (anti-β2GPI) antibodies stimulates tissue factor (TF) expression within vasculature and in blood cells, thereby leading to increased thrombosis. Several cellular receptors have been proposed to mediate these effects, but no convincing evidence for the involvement of a specific one has been provided. We investigated the role of Apolipoprotein E receptor 2 (ApoER2′) on the pathogenic effects of a patient-derived polyclonal aPL IgG preparation (IgG-APS), a murine anti-β2GPI monoclonal antibody (E7) and of a constructed dimeric β2GPI I (dimer), which in vitro mimics β2GPI-antibody immune complexes, using an animal model of thrombosis, and ApoER2-deficient (-/-) mice. In wild type mice, IgG-APS, E7 and the dimer increased thrombus formation, carotid artery TF activity as well as peritoneal macrophage TF activity/expression. Those pathogenic effects were significantly reduced in ApoER2 (-/-) mice. In addition, those effects induced by the IgG-APS, by E7 and by the dimer were inhibited by treatment of wild-type mice with soluble binding domain 1 of ApoER2 (sBD1). Altogether these data show that ApoER2 is involved in pathogenesis of antiphospholipids antibodies.

AB - Antiphospholipid (aPL)/anti-β2 glycoprotein I (anti-β2GPI) antibodies stimulates tissue factor (TF) expression within vasculature and in blood cells, thereby leading to increased thrombosis. Several cellular receptors have been proposed to mediate these effects, but no convincing evidence for the involvement of a specific one has been provided. We investigated the role of Apolipoprotein E receptor 2 (ApoER2′) on the pathogenic effects of a patient-derived polyclonal aPL IgG preparation (IgG-APS), a murine anti-β2GPI monoclonal antibody (E7) and of a constructed dimeric β2GPI I (dimer), which in vitro mimics β2GPI-antibody immune complexes, using an animal model of thrombosis, and ApoER2-deficient (-/-) mice. In wild type mice, IgG-APS, E7 and the dimer increased thrombus formation, carotid artery TF activity as well as peritoneal macrophage TF activity/expression. Those pathogenic effects were significantly reduced in ApoER2 (-/-) mice. In addition, those effects induced by the IgG-APS, by E7 and by the dimer were inhibited by treatment of wild-type mice with soluble binding domain 1 of ApoER2 (sBD1). Altogether these data show that ApoER2 is involved in pathogenesis of antiphospholipids antibodies.

UR - http://www.scopus.com/inward/record.url?scp=79251578627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251578627&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-07-299099

DO - 10.1182/blood-2010-07-299099

M3 - Article

VL - 117

SP - 1408

EP - 1414

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -